Lv3
400 积分 2024-01-22 加入
Mechanisms of GLP-1 Receptor Agonist-Induced Weight Loss: A Review of Central and Peripheral Pathways in Appetite and Energy Regulation
1小时前
待确认
Once-weekly semaglutide 7·2 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial
2天前
已完结
Comparison of Dose Escalation Versus Switching to Tirzepatide Among People With Type 2 Diabetes Inadequately Controlled on Lower Doses of Dulaglutide
6天前
已完结
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity
6天前
已完结
Association between glucagon‐like peptide ‐1 receptor agonists and risk of suicidality: A comprehensive analysis of the global pharmacovigilance database
9天前
已完结
Glucagon-Like Peptide 1 Receptor Agonists and Mental Health
9天前
已完结
Amylin and the renin-angiotensin system: risk or opportunity in amylin-based therapy?
1个月前
已完结
Safety and Tolerability of Glucagon-Like Peptide-1 Receptor Agonists: A State-of-the-Art Narrative Review
1个月前
已完结
Myostatin/Activin Receptor Ligands in Muscle and the Development Status of Attenuating Drugs
1个月前
已完结
Bimagrumab: an investigational human monoclonal antibody against activin type II receptors for treating obesity
1个月前
已完结
皖公网安备34019202002308
